Listed

Grace Therapeutics, Inc.

GRCENasdaqCIK 1444192HealthcareFiscal year ends Mar 31

All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.

What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.

By month, by reported value, last 24 monthsPurchases $158.6kSales $0
Grace Therapeutics, Inc., insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2026-10-26Opaleye Management Inc.10% owner Purchase66,411$1.7679$117.4kForm 4
2026-10-22Opaleye Management Inc.10% owner Purchase21,390$1.9258$41.2kForm 4

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.